Molecular Determinant of DIDS Analogs Targeting RAD51 Activity.
RAD51 is the central protein in DNA repair by homologous recombination (HR), involved in several steps of this process. It is shown that overexpression of the RAD51 protein is correlated with increased survival of cancer cells to cancer treatments. For the past decade, RAD51 overexpression-mediated resistance has justified the development of targeted inhibitors. One of the first molecules described to inhibit RAD51 was the 4,4'-diisothiocyanato-stilbene-2,2'-disulfonic acid (DIDS) molecule. This small molecule is effective in inhibiting different functions of RAD51, however its mode of action and the chemical functions involved in this inhibition have not been identified. In this work, we used several commercial molecules derived from DIDS to characterize the structural determinants involved in modulating the activity of RAD51. By combining biochemical and biophysical approaches, we have shown that DIDS and two analogs were able to inhibit the binding of RAD51 to ssDNA and prevent the formation of D-loop by RAD51. Both isothiocyanate substituents of DIDS appear to be essential in the inhibition of RAD51. These results open the way to the synthesis of new molecules derived from DIDS that should be greater modulators of RAD51 and more efficient for HR inhibition.
['Velic|Denis|D|', 'Demeyer|Alexandre|A|', 'Peterlini|Thibaut|T|', 'Benhelli-Mokrani|Houda|H|0000-0001-9501-0735', 'Mathé-Allainmat|Monique|M|', 'Masson|Jean-Yves|JY|', 'Fleury|Fabrice|F|0000-0002-6764-5060']
D017878:4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid D012856:4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid D004277:DNA, Single-Stranded D004305:Dose-Response Relationship, Drug D051135:Rad51 Recombinase
RAD51 cancer inhibitor recombinase activity stilbene derivatives